Katalin Csordás

Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia

Katalin Csordás, Márta Hegyi, Olivér Eipel et al. · Anti-Cancer Drugs · 2012 · 72 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Early Experience With CliniMACS Prodigy CCS (IFN-gamma) System in Selection of Virus-specific T Cells From Third-party Donors for Pediatric Patients With Severe Viral Infections After Hematopoietic Stem Cell Transplantation

Krisztián Kállay, Csaba Kassa, Marienn Réti et al. · Journal of Immunotherapy · 2017 · 67 citations

Medicine, Hematology, Pediatrics +17

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma

Márta Hegyi, Ádám Arany, Ágnes F. Semsei et al. · Oncotarget · 2016 · 50 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance

Orsolya Lautner‐Csorba, András Gézsi, Ágnes F. Semsei et al. · BMC Medical Genomics · 2012 · 47 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Associations of novel genetic variations in the folate‐related and <i><scp>ARID</scp>5<scp>B</scp></i> genes with the pharmacokinetics and toxicity of high‐dose methotrexate in paediatric acute lymphoblastic leukaemia

Katalin Csordás, Orsolya Lautner‐Csorba, Ágnes F. Semsei et al. · British Journal of Haematology · 2014 · 43 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15